Cargando…

Association between body mass index and mortality in hospitalised patients with community-acquired pneumonia

The obesity paradox postulates that increased body mass index (BMI) is protective in certain patient populations. We aimed to investigate the association of BMI and different weight classes with outcomes in hospitalised patients with community-acquired pneumonia (CAP). This cohort study is a seconda...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Richard Y., Glick, Connor, Furmanek, Stephen, Ramirez, Julio A., Cavallazzi, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983275/ https://www.ncbi.nlm.nih.gov/pubmed/33778059 http://dx.doi.org/10.1183/23120541.00736-2020

Ejemplares similares

Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Bradley, James, et al.
Publicado: (2022)

In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza
por: Spindel, Jeffrey, et al.
Publicado: (2023)

Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Ali, Ahmed Shebl, et al.
Publicado: (2023)

Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia
por: Sheikh, Daniya, et al.
Publicado: (2022)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

The upper respiratory tract microbiome of hospitalised patients with community-acquired pneumonia of unknown aetiology: a pilot study
por: Wiemken, Timothy L., et al.
Publicado: (2015)

2110. Immunocompromised Adults Hospitalized with Community-Acquired Pneumonia in the United States: Incidence and Clinical Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2022)

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

Viral infection in community-acquired pneumonia: a systematic review and meta-analysis
por: Burk, Michael, et al.
Publicado: (2016)

2195. Incidence of Acute Myocardial Infarction in Patients with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Nieto Dominguez, Alejandro, et al.
Publicado: (2019)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae
por: Chandler, Thomas, et al.
Publicado: (2022)

Influenza and Viral Pneumonia
por: Cavallazzi, Rodrigo, et al.
Publicado: (2018)

Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia
por: Bordon, Jose, et al.
Publicado: (2021)

Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia
por: Wetzke, Martin, et al.
Publicado: (2023)

Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia
por: Fernandez-Botran, Rafael, et al.
Publicado: (2014)

Processes of care for community-acquired pneumonia
por: Ramírez, Julio A.
Publicado: (2004)

Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
por: Carugati, Manuela, et al.
Publicado: (2018)

Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998–2014
por: Quan, T Phuong, et al.
Publicado: (2016)

Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
por: Chakrabarti, Biswajit, et al.
Publicado: (2021)

Discovery and predictive modeling of urine microbiome, metabolite and cytokine biomarkers in hospitalized patients with community acquired pneumonia
por: Pierre, Joseph F., et al.
Publicado: (2020)

External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia
por: Nüllmann, Harald, et al.
Publicado: (2014)

Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis
por: Spoorenberg, Simone MC, et al.
Publicado: (2014)

Response
por: Chandler, Thomas R., et al.
Publicado: (2023)

Mortality of Community-Acquired Pneumonia in Korea: Assessed with the Pneumonia Severity Index and the CURB-65 Score
por: Kim, Hye In, et al.
Publicado: (2013)

Association of body mass index with morbidity in patients hospitalised with COVID-19
por: Plataki, Maria, et al.
Publicado: (2021)

Pneumonia severity index in viral community acquired pneumonia in adults
por: Kim, Mi-Ae, et al.
Publicado: (2019)

Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States
por: Ramirez, Julio, et al.
Publicado: (2023)

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies
por: Ramirez, Julio A., et al.
Publicado: (2020)

Body Mass Index and Mortality
por: Yoo, Hye Jin
Publicado: (2017)

Early mobilisation of patients with community-acquired pneumonia reduce length of hospitalisation—a pilot study
por: Melgaard, Dorte, et al.
Publicado: (2018)

Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England
por: Campling, James, et al.
Publicado: (2020)

Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: a multicentre, prospective study
por: Lokida, Dewi, et al.
Publicado: (2022)

Impact of frailty on 30-day and 1-year mortality in hospitalised elderly patients with community-acquired pneumonia: a prospective observational study
por: Luo, Jia, et al.
Publicado: (2020)

Community Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2019)

Community-Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2017)

Charlson Comorbidity Index and other predictors of in-hospital mortality among adults with community-acquired pneumonia
por: Bahlis, Laura Fuchs, et al.
Publicado: (2021)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Biomarkers of Cardiac Dysfunction and Mortality from Community-Acquired Pneumonia in Adults
por: Chang, Catherina L., et al.
Publicado: (2013)

Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia
por: Huang, Sha, et al.
Publicado: (2022)

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
por: Filion, Kristian B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_18hdb72bo4vuq997qhdbtifd95